北京大学学报(医学版) ›› 2018, Vol. 50 ›› Issue (6): 1108-1111. doi: 10.19723/j.issn.1671-167X.2018.06.030

• 病例报告 • 上一篇    下一篇

系统性红斑狼疮合并获得性血友病A 1例

杨帆,周云杉,贾园()   

  1. 北京大学人民医院风湿免疫科,北京100044
  • 收稿日期:2018-06-03 出版日期:2018-12-18 发布日期:2018-12-18
  • 通讯作者: 贾园 E-mail:jiayuan1023@sina.com

Systemic lupus erythematosus with acquired hemophilia A: a case report

Fan YANG,Yun-shan ZHOU,Yuan JIA()   

  1. Department of Rheumatology and Immunology,Peking University People’s Hospital, Beijing 100044, China
  • Received:2018-06-03 Online:2018-12-18 Published:2018-12-18
  • Contact: Yuan JIA E-mail:jiayuan1023@sina.com

关键词: 系统性红斑狼疮, 获得性血友病A, 免疫抑制剂

Abstract:

Acquired hemophilia A (AHA) is anunusual disease resulting from autoantibodies (inhibitors) against coagulation factor Ⅷ (FⅧ) and clinically manifests as bleeding, which sometimes can cause potentially limb-threatening or life-threatening situations. AHA is associated with cancers, auto-immune disorders, infections, dermatologic conditions and certain medications, among which it is commonly secondary to multiple rheumatologic conditions,such as rheumatoid arthritis, systemic lupus erythematosus (SLE), pollymyositis, autoimmune hemolytic anemia and undifferentiated connective tissue disease. In autoimmune diseases, it may be the result of autoantibody producing against FⅧ, and some cases of AHA may act as the first manifestation of SLE. AHA should be suspected in patients who have spon-taneously hemorrhagic events with an isolated prolonged activated partial thromboplastin time (APTT), reduced FⅧ activity and a negative lupus anticoagulant (LA). When FⅧ inhibitor is found, it can be diagnosed. The management of AHA focuses on the following goals: (1)controlling and preventing blee-ding,(2)eradication of the inhibitor,(3)treatment of the underlying disease. Here, a case of AHA in a patient with lupus is reported. A 53-year-old man with a 4-year history of SLE developed arthralgia and ecchymotic skin lesions after arthrocentesis of knee joint. Ultrasound confirmed the presence of an intramuscular hematoma. Coagulation tests revealed that FⅧ activity reduced to 1% and a prolonged APTT (92.2 s), FⅧ inhibitors were found to be as high as 60.0 Bethesda Units. Initial treatments with me-thylprednisolone 200 mg/d were started but new hemorrhagic manifestation occurred and hisbiological indexes were not good. Then the patient was treated with intravenous pulse corticosteroids (methylprednisolone 500 mg/d),intravenous cyclophosphamide, and also plasma and prothrombin complex infusion. Sub-sequently, FⅧ activity returned within normal ranges, FⅧ inhibitors decreased and clinical improvement was significantly obtained. The patient’s condition kept stable till now.Hemorrhagic events due to produc-tion of antibodies directed against coagulation factors were rarely observed in SLE and attentions should be paid to the association between SLE and AHA.Bypass treatment was considered as the immediate antihemorrhagic treatment. Corticosteroid combined with immunosuppressor was recommended as the main therapy to eradicate the inhibitors. However we still lack the therapeutic guide-lines and standar-dized treatment in patients of AHA with SLE at present.

Key words: Systemic lupus erythematosus, Acquired hemophilia A, Immunosuppressor

中图分类号: 

  • R593.24

图1

患者多发皮下瘀斑及肌肉血肿"

[1] 郑东辉, 张白玉, 戴冽 , 等. 自身免疫性疾病合并获得性血友病A 4例临床分析并文献复习[J]. 中华风湿病学杂志, 2009,13(10):719-720.
doi: 10.3760/cma.j.issn.1007-7480.2009.10.019
[2] 冯云路, 郑文洁, 李剑 , 等. 结缔组织病相关获得性血友病甲4例报告并文献复习[J]. 北京医学, 2010,32(2):83-85.
doi: 10.3969/j.issn.1673-5552.2006.07.039
[3] O’Connor CR . Systematic reviewof thepresentation of coagulationfactor Ⅷ inhibitors in rheumatic diseases: a potential cause of life-threatening hemorrhage[J]. Semin Arthritis Rheum, 2015,44(6):695-709.
doi: 10.1016/j.semarthrit.2014.11.008 pmid: 25595725
[4] Delgado J, Jimenez-Yuste V, Hernandez-Navarro F , et al. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors[J]. Br J Haematol, 2003,121(1):21-35.
doi: 10.1046/j.1365-2141.2003.04162.x pmid: 12670328
[5] Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L , et al. Younger age at presentation of acquired haemophilia A in Asian countries: a single-centre study and systematic review[J]. Haemophilia, 2014,20(3):e205-e210.
doi: 10.1111/hae.12383 pmid: 24847520
[6] Collins PW, Hirsch S, Baglin TP , et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation[J]. Blood, 2007,109(5):1870-1877.
doi: 10.1182/blood-2006-06-029850 pmid: 17047148
[7] Knoebl P, Marco P, Baudo F , et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)[J]. Thromb Haemost, 2012,10(4):622-631.
doi: 10.1111/j.1538-7836.2012.04654.x pmid: 22321904
[8] Khodamoradi Z, Nazarinia MA, Bazdar S . Acquired hemophilia as initial presentation in a patient with systemic lupus erythematosus[J]. CurrRheumatol Rev, 2017,13(3):236-238.
doi: 10.2174/1573397113666170519121952 pmid: 28523993
[9] 白松婷, 盛光耀 . 1-脱氨基-8-D-精氨酸血管加压素治疗血友病的研究进展[J]. 中华妇幼临床医学杂志, 2011,7(5):476-480.
doi: 10.3877/cma.j.issn.1673-5250.2011.05.020
[10] 中华医学会血液学分会血栓与止血学组, 中国血友病协作组. 获得性血友病A诊断与治疗中国专家共识[J]. 中华血液学杂志, 2014,35(6):575-576.
doi: 10.3760/cma.j.issn.0253-2727.2014.06.026
[11] Huth-Kühne A, Baudo F, Collins P , et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A[J]. Haematologica, 2009,94(4):566-575.
doi: 10.3324/haematol.2008.001743
[12] Kruse-Jarres R, Kempton CL, Baudo F , et al. Acquired hemophilia A: pdated review of evidence and treatment guidance[J]. Am J Hematol, 2017,92(7):695-705.
doi: 10.1002/ajh.24777 pmid: 28470674
[1] 肖榆冰,郭慕瑶,左晓霞. 免疫代谢与系统性红斑狼疮[J]. 北京大学学报(医学版), 2018, 50(6): 1120-1124.
[2] 刘爽,郭雨龙,杨静逸,王维,徐健. 间充质干细胞治疗系统性红斑狼疮有效性的meta分析[J]. 北京大学学报(医学版), 2018, 50(6): 1014-1021.
[3] 孙雯,郭宏波,解泽林,张磊,田野,林俊. 肾移植患者术后腹泻的相关因素分析[J]. 北京大学学报(医学版), 2013, 45(5): 779-781.
[4] 肖锋, 张鲁锋, 石志辉. 西罗莫司给药方式对静脉移植物内膜增生的影响[J]. 北京大学学报(医学版), 2006, 38(5): 515-518.
[5] 何其华, 周慧芳, 薛冰, 牛东滨, 王晓民. 雷公藤单体T10对谷氨酸所致PC12细胞损伤的保护作用及机制研究[J]. 北京大学学报(医学版), 2003, 35(3): 252-255.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 万有, , 韩济生, John E. Pintar. 孤啡肽基因敲除小鼠电针镇痛作用增强[J]. 北京大学学报(医学版), 2009, 41(3): 376 -379 .
[2] Jian-wei GU, Emily YOUNG, Zhi-jun PAN, Kevan B. TUCKER, Megan SHPARAGO, Min HUANG, Amelia Purser BAILEY. SD大鼠长期高盐饮食可导致其高血压并改变肾细胞因子基因表达谱[J]. 北京大学学报(医学版), 2009, 41(5): 505 -515 .
[3] 李宏亮*, 安卫红*, 赵扬玉, 朱曦. 妊娠合并高脂血症性胰腺炎行血液净化治疗1例[J]. 北京大学学报(医学版), 2009, 41(5): 599 -601 .
[4] 李伟军, 邢晓芳, 曲立科, 孟麟, 寿成超. PRL-3基因C104S位点突变体和CAAX缺失体的构建及表达[J]. 北京大学学报(医学版), 2009, 41(5): 516 -520 .
[5] 汪毅, 刘粹, 王玉凤. 社会技能训练对有行为问题儿童影响的随机对照研究[J]. 北京大学学报(医学版), 2007, 39(3): 315 -318 .
[6] 丰雷, 程嘉, 王玉凤. 注意缺陷多动障碍儿童的运动协调功能[J]. 北京大学学报(医学版), 2007, 39(3): 333 -336 .
[7] 王海燕. 办好病例分析类栏目 为提高临床诊疗水平提供新平台[J]. 北京大学学报(医学版), 2007, 39(4): 341 .
[8] 牟向东, 王广发, 刁小莉, 阙呈立. 肺黏膜相关淋巴组织型边缘区B细胞淋巴瘤一例[J]. 北京大学学报(医学版), 2007, 39(4): 346 -350 .
[9] 徐涛, 赵卫红, 王晓峰, 黄晓波, 许清泉, 杨波, 叶雄俊. 盆腔脂肪增多症两例兄弟患者报道及文献分析[J]. 北京大学学报(医学版), 2007, 39(4): 355 -360 .
[10] 韩金涛, 赵军, 栾景源, 张龙. 多发结核性腹主动脉瘤一例[J]. 北京大学学报(医学版), 2007, 39(4): 361 -364 .